Research

Energy balance

There was no significant difference in the cost of diabetes therapy between the two groups (p = 0.12).

Practitioners can consider that an open formulary may improve glycemic control without increasing costs.

StrongSupportsmedium confidence
There was no significant difference in the cost of diabetes therapy between the two groups ( p = 0.12).
Tinh Duong et al. · JACCP JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY · 2024

Why this rating

The study is a retrospective cohort study with clear outcomes.

Source

Impact of a Restrictive Formulary on glycemic control compared with an Open Formulary

Tinh Duong et al. · JACCP JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY · 2024

DOI 10.1002/jac5.2048

cohort
Read the paper
DOI resolved against Crossref · corpus check 2026-06-10

This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →